Cilpla Enters Into A Licensing Agreement Eli Lilly To Make And Sell Baricitinib To Treat Covid-19
Indian drugmaker Cipla Ltd has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly’s arthritis drug baricitinib for the treatment of Covid-19…
Share